Discussions about how to recruit tricky or hard-to-reach patients in market research are common - in fact, we've written a number of blogs on the subject ourselves. But the issue of what happens in market research with patients after recruitment is complete is less touched upon.
Wearable technology may be relatively new, but it's already having a huge impact on the healthcare industry. From sensors that monitor blood pressure or predict heart attacks, to those showing surgeons how many steps patients take after cardiac surgery, patients and clinicians are already seeing big benefits. Something that looks likely to continue. What these innovations can achieve in the future seems limitless. Those in the know anticipate massive growth in wearable technology over the next few years - some estimates predict the global market will be worth over $6 billion by 2018. Over a third of the wearable tech used today is health related, largely thanks to widespread diabetes and an aging global population. Those are some big numbers, so it's no surprise the healthcare industry is at the forefront of exploring the possibilities of this imminent boom.
To the uninitiated, healthcare may not seem like a fast-moving area. After all, the NHS is the largest employer in the UK so it would be logical that it would take a long time for such a big ship to change course. In practice, however, this perception could not be further from the truth and the NHS is in an almost constant state of flux. Keeping up with the shifting sands of healthcare can seem like a full-time job, so we offer a quick snapshot of the most important recent changes.
As market researchers, we're always on the look out for new ways to collect data more effectively and improve our healthcare fieldwork - the industry's been that way since taking its tentative first steps back in the early 20th century. This constant drive to evolve means market research has seen lots of ground-breaking innovations over the past 100 years or so. Now, we're wrestling with the best way to use one of the newest kids on the block - neuroscience.
At GKA our strength in recruiting and conducting patient studies in Parkinson's disease (PD) allows us to get a true understanding of what people living with PD face every day. Parkinson's disease is a progressive neurological condition which can be symptomatically treated, but not cured. Treatments aim to reduce symptoms and maintain quality of life by replacing or preserving dopamine in the brain. Dopamine is involved in the coordination and control of movement, and as the levels progressively fall as PD worsens, the symptoms of Parkinson's start to appear.
Healthcare market research agency GKA, conducts patient fieldwork in a broad range of therapy areas. GKA has extensive experience in larger disease areas, such as diabetes, asthma and oncology, and the expert team routinely recruits patients with conditions as diverse as haemophilia, HIV/AIDS, rheumatoid arthritis, heart disease, obesity, epilepsy, fibromyalgia and Parkinson's disease.
For more than 20 years, our team has established an industry-leading track record and robust reputation in identifying and recruiting patients for healthcare market research studies. The challenges in finding the right patients for the right study are many...
A deeper understanding of the patient experience is invaluable for pharmaceutical companies seeking to deliver next generation therapies. After all, patients have a unique perspective on disease and treatment, a view that is often ignored and always very different from the experience of the healthcare professionals who treat them.
Recognising the value of the knowledge acquired by all of its colleagues across the years, medical fieldwork agency GKA has built its own internal Wiki comprising rich data not easily found anywhere else.